BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-07-13: Reporting owner Flynn Harold C Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-27: Reporting owner MOLL FREDERIC H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-27: Reporting owner TALEVICH JAMES R; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-27: Reporting owner LORD JONATHAN T MD; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-07-13 | Flynn Harold C Jr. Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +870,000 870,000 owned after | $1.65 exercise price | 2015-07-20 | |
| 2015-04-27 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,159 230,837 owned after | $2.27 exercise price | 2015-04-29 | |
| 2015-04-27 | TALEVICH JAMES R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +138,767 207,695 owned after | $2.27 exercise price | 2015-04-29 | |
| 2015-04-27 | LORD JONATHAN T MD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,159 173,587 owned after | $2.27 exercise price | 2015-04-29 | |
| 2015-04-27 | CLARK PAUL N Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +254,405 319,583 owned after | $2.27 exercise price | 2015-04-29 | |
| 2015-03-09 | DREYER DAVID C Officer (SVP / Chief Financial Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +871,710 871,710 owned after | $1.99 exercise price | 2015-06-25 | |
| 2015-03-09 | DREYER DAVID C Officer (SVP / Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +871,710 871,710 owned after | $1.99 exercise price | 2015-03-19 |